4//SEC Filing
KARBE FRANK 4
Accession 0000950170-24-136391
CIK 0001783183other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 8:05 AM ET
Size
5.0 KB
Accession
0000950170-24-136391
Insider Transaction Report
Form 4
KARBE FRANK
Director
Transactions
- Purchase
Common Stock
2024-12-13$7.93/sh+12,500$99,084→ 57,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.87 to $8.00. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001276700
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 8:05 AM ET
- Size
- 5.0 KB